Back to Press
Blog

HIPEC: A Key Tool in the Successful Fight Against Peritoneal Carcinomatosis

December 28, 2024
10 min read
6,123 views
HIPEC: A Key Tool in the Successful Fight Against Peritoneal Carcinomatosis

Dr. med. Michael Lipp is one of the most experienced colorectal surgeons in Germany, specializing in HIPEC treatment. During his 18 years of active clinical practice, he has published more than 60 scientific papers.

Understanding HIPEC

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is an innovative treatment approach that combines surgery with heated chemotherapy delivered directly to the abdominal cavity. This method has shown remarkable success in treating peritoneal carcinomatosis.

Success Rates and Outcomes

Studies demonstrate that HIPEC can significantly improve survival rates for patients with advanced abdominal cancers, offering new hope where traditional treatments have limited effectiveness.

Share this article

Help others discover this content

Related Articles

More articles coming soon

We're constantly adding new medical insights and interviews